In 2016, the North American synthetic opioids market was dominated by the semi-synthetic opioids category, which is projected to increase its market share by more than 10 BPS by 2024. By 2024, it is anticipated that the semi-synthetic opioids market would be worth more than US$ 80 billion, growing at a 2.5% CAGR. In comparison to 2015, the segment’s revenue in the North American synthetic opioids market is anticipated to increase 1.25X by 2024’s end.
Request for Free Sample Copy@ https://www.persistencemarketresearch.com/samples/15898
In terms of revenue, the semi-synthetic opioids segment dominated the North American synthetic opioids market in 2016 and is anticipated to do so for the duration of the forecast. The semi-synthetic product type sector, with an attractiveness index of 1.8 throughout the projected period, is likely to continue to be a desirable market segment.
The expansion of the North American synthetic opioids market would be boosted by the launch of innovative opioids, particularly in abuse deterrent formulations. The market for branded opiates is anticipated to be fueled by new drugs with creative pharmacological designs and formulations, such as the abuse-deterrent compositions found in Oxycontin and Opana.
Get up to 20% discount on Full Report Purchase @ https://www.persistencemarketresearch.com/checkout/15898
Additionally, the U.S. Food and Drug Administration is pressuring pharmaceutical companies to create new medications that are less alluring to addicts. One of the main growth drivers for the semi-synthetic opioids market in North America is the rise in new drug applications by pharmaceutical companies and the quantity of items in their pipeline.
Companies Covered in This Report – North America Synthetic Opioids Market
-
- Purdue Pharma LP
- Pfizer Inc.
- Janssen Pharmaceuticals, Inc.
- Teva Pharmaceuticals
- Endo International plc
- West-Ward Pharmaceuticals (Hikma’s US subsidiary)
- Mallinckrodt Pharmaceuticals plc
- Mylan N.V.
- Impax Laboratories, Inc
- Indivior Plc.
Request For Customization @ https://www.persistencemarketresearch.com/request-customization/15898
North America Synthetic Opioids Market : Market Segmentation
-
- North America Synthetic Opioids Market By Country : S, Canada
- North America Synthetic Opioids Market By Product Type : Synthetic Opioids : Methadone, , Fentanyl, Meperidine, Semi-Synthetic Opioids : Hydrocodone, Oxymorphone, Oxycodone, Hydromorphone, Buprenorphine
- North America Synthetic Opioids Market By Application : Pain Management, De-addiction
- North America Synthetic Opioids Market By Distribution Channel : Retail Outlet, Hospitals
Related Reports:
About Us:
Persistence Market Research’s Expertise in Life Sciences and Transformational Health
Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.
Contact Us:
Persistence market research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com